Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  GlobalData

GlobalData Market Research Reports

GlobalData is the premier source of actionable insight into the energy and healthcare industries. With the combined expertise of more than 1,000 researchers, market analysts and consultants, we provide high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

Combining precision with innovation, our research and consulting solutions ensure our clients stay at the forefront of their markets by integrating accurate market forecasts and analysis on the latest trends and developments with the unrivalled expertise of our analyst teams. Among other benefits, our informed industry perspectives help clients understand how to generate the maximum return from their key markets, identify opportunities from emerging trends, and devise strategies for growth with confidence. 



UK Power Market Outlook to 2025, Update 2015 - Market Trends, Regulations, and Competitive Landscape
This report elaborates the UK’s power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the UK power market’s regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in the UK on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential. Financial performance of the leading power companies is also analyzed in the report. Scope Snapshot of the country’s power sector across parameters macro economics, supply security, generation i
Published Date: Apr 2015
Published By: GlobalData

Price: $2500
LNG Industry Outlook in Europe to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
LNG Industry Outlook in Europe to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals"" is a comprehensive report on Europe LNG Industry. The report provides asset details of all active and planned, LNG liquefaction and regasification terminals in the region by country. Information by terminal includes terminal name, operator company name and design LNG processing capacity (liquefaction / regasification) for the period 2009-2019. Planned (new build) LNG terminals capacity addition and existing capacity expansions, as announced by the companies have also been included. The report provides LNG liquefaction and regasification capital expenditure outlook at regional level by year as well as by key countries till 2019. Further the report also of
Published Date: Mar 2015
Published By: GlobalData

Price: $5000
Drug Eluting Stents (DES) - Pipeline Review, 2015
GlobalData's Medical Devices sector report, “Drug Eluting Stents (DES) Pipeline Review, 2015"" provides an overview of Drug Eluting Stents currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key drug eluting stents pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. Scope Extensive coverage of the
Published Date: Mar 2015
Published By: GlobalData

Price: $4000
Wound Closure Devices - Pipeline Review, 2015
GlobalData's Medical Devices sector report, “Wound Closure Devices Pipeline Review, 2015"" provides an overview of Wound Closure Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key wound closure devices pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. Scope Extensive coverage of the
Published Date: Mar 2015
Published By: GlobalData

Price: $4000
Wind Power in Turkey, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Wind Power in Turkey, Market Outlook to 2025, Update 2015 Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the wind power market in Turkey. The report provides in depth analysis on global renewable power market and global wind power market with forecasts up to 2025. The report analyzes the power market scenario in Turkey (includes conventional thermal, nuclear, large hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes wind, small hydro, biopower and solar PV) and provides forecas
Published Date: Mar 2015
Published By: GlobalData

Price: $2500
Qatar Al-Khaleej Gas Project-2 Project Panorama - Oil and Gas Upstream Analysis Report
Qatar Al-Khaleej Gas Project-2 Project Panorama, GlobalData’s latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview,
Published Date: Mar 2015
Published By: GlobalData

Price: $1000
United Arab Emirates Bab Project Panorama - Oil and Gas Upstream Analysis Report
United Arab Emirates Bab Project Panorama, GlobalData’s latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geolo
Published Date: Mar 2015
Published By: GlobalData

Price: $1000
LNG Industry Outlook in Asia and Oceania to 2019 - Capacity and Capital Expenditure Forecasts With Details of All Operating and Planned Terminals
LNG Industry Outlook in Asia and Oceania to 2019 Capacity and Capital Expenditure Forecasts With Details of All Operating and Planned Terminals"" is a comprehensive report on Asia and Oceania LNG industry. The report provides asset details of all active and planned, LNG liquefaction and regasification terminals in the region by country. Information by terminal includes terminal name, operator company name and design LNG processing capacity (liquefaction / regasification) for the period 2009-2019. Planned (new build) LNG terminals capacity addition and existing capacity expansions, as announced by the companies have also been included. The report provides LNG liquefaction and regasification capital expenditure outlook at regional level by year as well as by key countries till 2019. Furthe
Published Date: Mar 2015
Published By: GlobalData

Price: $5000
LNG Industry Outlook in Middle East and Africa to 2019 - Capacity and Capital Expenditure Forecasts With Details of All Operating and Planned Terminals
LNG Industry Outlook in Middle East and Africa to 2019 Capacity and Capital Expenditure Forecasts With Details of All Operating and Planned Terminals"" is a comprehensive report on Middle East and Africa LNG industry. The report provides asset details of all active and planned, LNG liquefaction and regasification terminals in the region by country. Information by terminal includes terminal name, operator company name and design LNG processing capacity (liquefaction / regasification) for the period 2009-2019. Planned (new build) LNG terminals capacity addition and existing capacity expansions, as announced by the companies have also been included. The report provides LNG liquefaction and regasification capital expenditure outlook at regional level by year as well as by key countries till
Published Date: Mar 2015
Published By: GlobalData

Price: $5000
LNG Industry Outlook in South America and Caribbean to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
LNG Industry Outlook in South America and Caribbean to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals"" is a comprehensive report on the South America and Caribbean LNG Industry. The report provides asset details of all active and planned, LNG liquefaction and regasification terminals in the region by country. Information by terminal includes terminal name, operator company name and design LNG processing capacity (liquefaction / regasification) for the period 2009-2019. Planned (new build) LNG terminals capacity addition and existing capacity expansions, as announced by the companies have also been included. The report provides LNG liquefaction and regasification capital expenditure outlook at regional level by year as well as by key c
Published Date: Mar 2015
Published By: GlobalData

Price: $5000
Hematological Tumor Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H1, 2015"" provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematological Tumor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDa
Published Date: Mar 2015
Published By: GlobalData

Price: $2500
EpiCast Report: Alzheimers Disease - Epidemiology Forecast to 2023
AD is an irreversible, neurodegenerative brain disease of the elderly, which leads to a progressive decline in memory and cognitive abilities, such as thinking, language, and learning capacity. Similar to AD, mild cognitive impairment (MCI) is also a condition of the elderly in which there is a slight but noticeable and measurable decline in cognitive abilities, including memory and thinking skills, but no dementia. To forecast the total prevalent cases of AD in adults ages =60 years in the 9MM during the forecast period (2013-2023), GlobalData epidemiologists identified country-specific population-based studies that used the diagnostic criteria based on the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM-III-R) to diagnose dementia, and the National
Published Date: Mar 2015
Published By: GlobalData

Price: $3995
EpiCast Report: Duchenne Muscular Dystrophy - Epidemiology Forecast to 2023
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are rare progressive muscle wasting disorders. GlobalData epidemiologists forecast that the diagnosed prevalent cases of DMD (all ages) in the 6MM will increase from 17,675 diagnosed prevalent cases in 2013 to 17,712 diagnosed prevalent cases in 2023, at an Annual Growth Rate (AGR) of 0.02%. The 6MM had an estimated 6,076 diagnosed prevalent cases of DMD for ages 5-13 years in 2013, and the number of diagnosed prevalent cases is expected to increase to 6,250 by 2023, at an AGR of 0.29%. GlobalData epidemiologists forecast that the diagnosed prevalent cases of DMD with nonsense mutations (all ages) in the 6MM will increase from 2,260 diagnosed prevalent cases in 2013 to 2,264 diagnosed prevalent cases in 2023, at an
Published Date: Mar 2015
Published By: GlobalData

Price: $3995
Medical Equipment Monthly Deals Analysis: January 2015 - M&A and Investment Trends
GlobalData's “Medical Equipment Monthly Deals Analysis: January 2015 M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in January 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the medical equipment industry. Data presented in this report is derived from GlobalD
Published Date: Mar 2015
Published By: GlobalData

Price: $1000
Medical Equipment Monthly Deals Analysis: February 2015 - M&A and Investment Trends
GlobalData's “Medical Equipment Monthly Deals Analysis: February 2015 M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in February 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the medical equipment industry. Data presented in this report is derived from Globa
Published Date: Mar 2015
Published By: GlobalData

Price: $1000
Power Monthly Deal Analysis - February 2015: M&A and Investment Trends
GlobalData's “Power Monthly Deal Analysis February 2015: M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the power industry in February 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the power industry. Data presented in this report is derived from GlobalData’s proprietary in-house Power deals da
Published Date: Mar 2015
Published By: GlobalData

Price: $1000
Equatorial Guinea Alba Project Panorama - Oil and Gas Upstream Analysis Report
Equatorial Guinea Alba Project Panorama, GlobalData’s latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geology
Published Date: Mar 2015
Published By: GlobalData

Price: $1000
Colombia Acordionero Project Panorama - Oil and Gas Upstream Analysis Report
Colombia Acordionero Project Panorama, GlobalData’s latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geology,
Published Date: Mar 2015
Published By: GlobalData

Price: $1000
Ghana Jubilee Project Panorama - Oil and Gas Upstream Analysis Report
Ghana Jubilee Project Panorama, GlobalData’s latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geology, challen
Published Date: Mar 2015
Published By: GlobalData

Price: $1000
Global Wind Turbine Operations & Maintenance Market, Update 2015 - Market Size, Major Contenders, Trends, and Analysis to 2020
Global Wind Turbine Operations & Maintenance Market, Update 2015 - Market Size, Major Contenders, Trends, and Analysis to 2020SummaryGlobal Wind Turbine Operations & Maintenance Market, Update 2015 - Market Size, Major Contenders, Trends, and Analysis to 2020, the latest report from industry analysis specialist GlobalData, offers comprehensive information and analysis of the global wind turbine operations and maintenance (O&M) market.The report provides a clear overview of and detailed insight into the global wind turbine O&M market. It explains the key drivers and challenges affecting the market and also provides data regarding historic and forecast market size, both globally and in the key wind power countries: US, Germany, Spain, UK, China and India.The report uses data and information
Published Date: Mar 2015
Published By: GlobalData

Price: $3995
Global Planned LNG Industry Outlook to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Planned Terminals
date information available on all planned liquefaction and regasification terminals globally- Identify growth segments and opportunities in the industry.- Facilitate decision making on the basis of strong forecast capacity data- Assess your competitors LNG assets
Published Date: Mar 2015
Published By: GlobalData

Price: $5000
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2015
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2015" provides data on the Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acu
Published Date: Mar 2015
Published By: GlobalData

Price: $2500
Myasthenia Gravis Global Clinical Trials Review, H1, 2015
Myasthenia Gravis Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, Myasthenia Gravis Global Clinical Trials Review, H1, 2015" provides data on the Myasthenia Gravis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myasthenia Gravis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myasthenia Gravis. This report is built using data and information sourced from proprietary databases, primary and secondar
Published Date: Mar 2015
Published By: GlobalData

Price: $2500
EpiCast Report: Sepsis - Epidemiology Forecast to 2023
EpiCast Report: Sepsis - Epidemiology Forecast to 2023SummarySepsis is a life-threatening complication arising from an infection; it occurs when the bodys response to the infection damages its own tissues and organs. Anyone can develop sepsis; however, the condition is more common among children
Published Date: Mar 2015
Published By: GlobalData

Price: $3995
Nuclear Power in Republic of Korea, Market Outlook to 2025, 2015 Update - Capacity, Generation, Power Plants, Regulations and Company Profiles
Nuclear Power in Republic of Korea, Market Outlook to 2025, 2015 Update - Capacity, Generation, Power Plants, Regulations and Company ProfilesSummary"Nuclear Power in Republic of Korea, Market Outlook to 2025, 2015 Update - Capacity, Generation, Power Plants, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the nuclear power market in Republic of Korea.The report provides in depth analysis on global nuclear power market with forecasts up to 2025. The report analyzes the power market scenario in Republic of Korea (includes thermal conventional, nuclear, large hydro, pumped storage and renewables) and provides future outlook with forecasts up to 2025. The research details nuclear
Published Date: Mar 2015
Published By: GlobalData

Price: $2500
Partnerships, Licensing, Investments and M&A Deals and Trends for January 2015 in Pharmaceuticals
Partnerships, Licensing, Investments and M&A Deals and Trends for January 2015 in PharmaceuticalsSummaryGlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for January 2015 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in January 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides
Published Date: Mar 2015
Published By: GlobalData

Price: $1000
Thermal Power in Turkey, Market Outlook to 2025, Update 2015 - Capacity, Generation, Power Plants, Regulations and Company Profiles
Thermal Power in Turkey, Market Outlook to 2025, Update 2015 Capacity, Generation, Power Plants, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the thermal power market. The report provides in depth analysis on global thermal power market with forecasts up to 2025. The report analyzes the power market scenario in Turkey(includes thermal, nuclear, large hydro, pumped storage and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details thermal power market outlook in the country and provides forecasts up to 2025. The report highlights installed capacity and power generation trends from 2001 to 2025 in Turkey thermal power
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Occidental Petroleum Corporation, Company Intelligence Report
Occidental Petroleum Corporation (Occidental) is an international oil and gas exploration and production company headquartered in Houston. It operates in the US, the Middle East and Latin America. As well as exploring and producing oil and gas, it is involved in midstream and downstream activities. Through its midstream and marketing segment, Occidental gathers, processes, transports, stores, purchases and markets oil, condensate, Natural Gas Liquids (NGL), natural gas, carbon dioxide (CO2) and power. Its subsidiary Occidental Chemical Corporation (OxyChem) manufacturers polyvinyl chloride (PVC) resins, chlorine and caustic soda, which is a key building block for a number of indispensable products, including plastics, pharmaceuticals and water-treatment chemicals. OxyChem also manufactur
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015"" provides data on the Anaplastic Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-hous
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Angiosarcoma Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H1, 2015"" provides data on the Angiosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Angiosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Angiosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015"" provides data on the Extrahepatic Bile Duct Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Extrahepatic Bile Duct Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Extrahepatic Bile Duct Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary rese
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H1, 2015"" provides data on the Follicular Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Follicular Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Follicular Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-hous
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Intestinal Cancer Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H1, 2015"" provides data on the Intestinal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intestinal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intestinal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015"" provides data on the Islet Cell Carcinoma (Insulinoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Islet Cell Carcinoma (Insulinoma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Islet Cell Carcinoma (Insulinoma). This report is built using data and information sourced from proprietary databases, primary an
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015"" provides data on the Myxoid Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myxoid Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myxoid Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's t
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Pilocytic Astrocytoma Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Pilocytic Astrocytoma Global Clinical Trials Review, H1, 2015"" provides data on the Pilocytic Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pilocytic Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pilocytic Astrocytoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Gl
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015"" provides data on the Round Cell Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Round Cell Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Round Cell Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis b
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015"" provides data on the Subependymal Giant Cell Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Subependymal Giant Cell Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Subependymal Giant Cell Astrocytoma. This report is built using data and information sourced from proprietary databases, pr
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Synovial Sarcoma Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Synovial Sarcoma Global Clinical Trials Review, H1, 2015"" provides data on the Synovial Sarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Synovial Sarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Synovial Sarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of i
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Thymus Carcinoma Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Thymus Carcinoma Global Clinical Trials Review, H1, 2015"" provides data on the Thymus Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thymus Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thymus Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of i
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Blood Glucose Meters - Pipeline Review, 2015
GlobalData's Medical Devices sector report, “Blood Glucose Meters Pipeline Review, 2015"" provides an overview of Blood Glucose Meters currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key blood glucose meters pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. Scope Extensive coverage of the Bl
Published Date: Feb 2015
Published By: GlobalData

Price: $4000
Acrostak (Schweiz) AG - Product Pipeline Analysis, 2015 Update
Acrostak (Schweiz) AG (Acrostak) is a medical device manufacturer. The company develops, manufactures and distributes single use medical devices in the fields of interventional cardiology, interventional radiology and interventional oncology. Its interventional cardiology products includes grip, across CTP, across HP and genieinterventional radiology products include PTA balloon catheters designed to dilate and treat infrapopliteal arteries with local delivery of anti-restenotic drug. It also provides solutions to improve the treatment of peripheral arterial diseases (PAD). Acrostak is headquartered in Winterthur, Switzerland. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key informati
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Acoustic MedSystems, Inc. - Product Pipeline Analysis, 2015 Update
Acoustic Medsystems, Inc. (AMS) is a medical equipments manufacturer. The company designs ultrasound and radiation therapy systems and instrumentation. Its products include radvision, a brachytherapy treatment planning system and theravision, an image-guided ultrasound ablation technology. It also offers products such as ablation and radiation treatment planning systems, delivery guidance software and systems, and high intensity needle-based and catheter-based interventional devices for thermal ablative therapy. AMS provides patient-specific planning, imaging, implants and applicator device alignment for treating cancer using radioactive seed implants and HDR afterloader devices, 2D and 3D anatomy, dose visualizations and post treatment seed localization. AMS is headquartered in Savoy, I
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Abbott Medical Optics, Inc. - Product Pipeline Analysis, 2015 Update
Abbott Medical Optics, Inc. (Abbott Medical), formerly Advanced Medical Optics, Inc., is an ophthalmic devices company. It carries out the discovery and delivery of vision technologies that optimize the quality of life for people. The company focuses on developing a broad suite of technologies and devices to address a wide range of vision disorders. It is a global specialist in the development, manufacture and marketing of surgical medical devices for eye and eye care products. Abbott Medical offers its products in three categories, namely, cataract, refractive and corneal products. The company operates in AmericasEurope, Africa and the Middle Eastand Asia-Pacific. It markets products in approximately 60 countries. Abbott Medical is a subsidiary of Abbott Laboratories and is headquarte
Published Date: Feb 2015
Published By: GlobalData

Price: $750
LifeScan, Inc - Product Pipeline Analysis, 2015 Update
LifeScan, Inc. (LifeScan) is a blood glucose monitoring company. The company undertakes the development, manufacture and marketing of blood glucose monitoring systems for home and hospital use. LifeScan’s product portfolio includes blood glucose meters, testing strips and control solutions, lancing devices, diabetes management software and tools and accessories. It also provides support services. The company has manufacturing facilities in Puerto Rico and Scotland. LifeScan markets its products across Africa, Asia Pacific, Eastern Europe, Europe, Latin America, the Middle East and North America. The company is a subsidiary of Johnson & Johnson. LifeScan is headquartered in Wayne, Pennsylvania, the US. This report is a source for data, analysis, and actionable intelligence on
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Roche Diagnostics International Ltd - Product Pipeline Analysis, 2015 Update
Roche Diagnostics International Ltd. (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devicesanalyzers, blood glucose meterslaboratory information, workflow and data management softwareand instruments and reagents for life science research. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. It has operations in the Americas, Asia Pacific, Africa, the Middle East and Europe. Roche Diagnostics manages all the central functions of the Diagnostics business of F. Hoffmann-La Roche Ltd. and is headquartered in Rotkreuz, Switzerland. This report
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Wind Power in Ireland, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Wind Power in Ireland, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company ProfilesSummary"Wind Power in Ireland, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles" is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the wind power market in Ireland.The report provides in depth analysis on global renewable power market and global wind power market with forecasts up to 2025. The report analyzes the power market scenario in Ireland (includes conventional thermal, nuclear, large hydro and renewable energy sources) and provides future outloo
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Wind Power in New Zealand, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Wind Power in New Zealand, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company ProfilesSummary"Wind Power in New Zealand, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles" is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the wind power market in New Zealand.The report provides in depth analysis on global renewable power market and global wind power market with forecasts up to 2025. The report analyzes the power market scenario in New Zealand (includes conventional thermal, nuclear, large hydro and renewable energy sources) and provid
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Geothermal Power in New Zealand, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Geothermal Power in New Zealand, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company ProfilesSummary"Geothermal Power in New Zealand, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles" is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the wind power market in New Zealand.The report provides in depth analysis on global renewable power market and global wind power market with forecasts up to 2025. The report analyzes the power market scenario in New Zealand (includes conventional thermal, nuclear, large hydro and renewable energy sources
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Wind Power in Sweden, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Wind Power in Sweden, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company ProfilesSummary"Wind Power in Sweden, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles" is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the wind power market in Sweden.The report provides in depth analysis on global renewable power market and global wind power market with forecasts up to 2025. The report analyzes the power market scenario in Sweden (includes conventional thermal, nuclear, large hydro and renewable energy sources) and provides future outlook wi
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Hydropower in Sweden, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Hydropower in Sweden, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company ProfilesSummary"Hydropower in Sweden, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles" is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the hydro power market in Sweden.The report provides in depth analysis on global renewable power market and global hydro power market with forecasts up to 2025. The report analyzes the power market scenario in Sweden (includes conventional thermal, nuclear, large hydro and renewable energy sources) and provides future outlook
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
United Kingdom Catcher Project Panorama - Oil and Gas Upstream Analysis Report
United Kingdom Catcher Project Panorama - Oil and Gas Upstream Analysis ReportSummaryUnited Kingdom Catcher Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential.Scope- Overview of the asset based on an analysis of the economic indicators- Key financial indicators including Net Present Value and Internal Rate of Return- Review of factors affecting the eco
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Thermal Power in Republic of Korea, Market Outlook to 2025, 2015 Update - Capacity, Generation, Power Plants, Regulations and Company Profiles
2025, 2015 Update - Capacity, Generation, Power Plants, Regulations and Company Profiles" is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the thermal power market.The report provides in depth analysis on global thermal power market with forecasts up to 2025. The report analyzes the power market scenario in Republic of Korea(includes thermal, nuclear, large hydro, pumped storage and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details thermal power market outlook in the country and provides forecasts up to 2025. The report highlights installed capacity and power generation trends from 2001 to 2025 in Republic of Korea thermal power market. A detailed coverage of
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Mozambique Upstream Fiscal and Regulatory Report
Mozambique Upstream Fiscal and Regulatory Report, GlobalDatas latest release, presents the essential information relating to the terms which govern investment into Mozambiques upstream oil and gas sector. The report sets out in detail the contractual framework which firms must operate in the industry, clearly defining factors affecting profitability and quantifying the states take from hydrocarbon production. Considering political, economic and industry specific variables, the report also analyses future trends for Mozambiques upstream oil and gas investment climate. Scope Overview of current fiscal terms governing upstream oil and gas operations in Mozambique Information on the legal framework and governing bodies administering the industry Information on the evolution of
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Laredo Petroleum, Company Intelligence Report
Laredo Petroleum, Inc. (Laredo) is an independent energy company in the US. It focuses on the exploration, development and acquisition of oil and liquids-rich natural gas in the US Permian Basin. The Permian Basin is one of the most prolific oil and liquids-rich natural gas regions of the US. The company is currently drilling locations in the Upper Wolfcamp, Middle Wolfcamp, Lower Wolfcamp and Cline Shales. Besides the Permian Basin, Laredo also undertakes operations in other areas within its core operating regions. Scope Key Highlights: This section provides detailed analysis on the companys overall oil and gas value chain, new projects, growth opportunities, new ventures, assets performance, Capex funding, geographical results of oil and gas operations. Goals and Strategie
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
LINN Energy LLC, Company Intelligence Report
LINN Energy LLC (LINN Energy) is an independent oil and natural gas company. It develops and acquires oil, Natural Gas Liquids (NGL) and gas assets. Its operations are spread across the US, with prominent assets in Wyoming, Utah, Colorado, East Texas and California. In August 2014, the company had a proved and probable reserve base of 7,900 billion cubic feet equivalent (bcfe). It is headquartered in Houston, Texas. Its core development and exploration activities are categorized into seven operating regions: the Rockies, the Mid-Continent, Hugoton Basin, California, Permian Basin, Michigan and Illinois-Antrim Shale, and East Texas. Scope Key Highlights: This section provides detailed analysis on the companys overall oil and gas value chain, new projects, growth opportunities,
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Mexico Zaap Project Panorama - Oil and Gas Upstream Analysis Report
Mexico Zaap Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geology, challenges, re
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Mexico Maloob Project Panorama - Oil and Gas Upstream Analysis Report
Mexico Maloob Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geology, challenges,
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Mexico Ku Project Panorama - Oil and Gas Upstream Analysis Report
Mexico Ku Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geology, challenges, rese
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Refining Industry Outlook in Middle East and Africa to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries
Refining Industry Outlook in Middle East and Africa to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries" is a comprehensive report on crude oil refining industry in Middle East and Africa. The report provides refinery details such as refinery name, country, and refinery operator name, with in-depth coverage on crude distillation unit or, CDU capacity and other major unit capacities for all active and planned refineries in the region. The report also provides refinery capital expenditure outlook for Middle East and Africa till 2019. The report provides key country comparisons within a region based on contribution to regional refining capacity as well as refining capacity growth. Further, the report also offers recent developments as we
Published Date: Feb 2015
Published By: GlobalData

Price: $5000
Refining Industry Outlook in South America, Central America and Caribbean to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries
Refining Industry Outlook in South America, Central America and Caribbean to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries" is a comprehensive report on crude oil refining industry in South America, Central America and Caribbean. The report provides refinery details such as refinery name, country and refinery operator name, with in-depth coverage on crude distillation unit or, CDU capacity and other major unit capacities for all active and planned refineries in the region. The report also provides refinery capital expenditure outlook for South America, Central America and Caribbean till 2019. The report provides key country comparisons within a region based on contribution to regional refining capacity as well as refining capacity
Published Date: Feb 2015
Published By: GlobalData

Price: $5000
Global Planned Refining Industry Outlook to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Planned Refineries
Global Planned Refining Industry Outlook to 2019 Capacity and Capital Expenditure Forecasts with Details of All Planned Refineries" is a comprehensive report on global planned crude oil refining industry. The report provides refinery details such as refinery name, country, and refinery operator name, with in-depth coverage on crude distillation unit or, CDU capacity and other major unit capacities for all planned refineries. The report also provides refinery capital expenditure outlook at global as well as regional level by year and by key countries till 2019. The report also provides comparison of key countries based on contribution to global as well as regional refining capacity. Further the report also offers recent developments as well as latest tenders and contracts at regional le
Published Date: Feb 2015
Published By: GlobalData

Price: $5000
End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015" provides data on the End-Stage Kidney Disease (end-stage renal disease or ESRD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on End-Stage Kidney Disease (end-stage renal disease or ESRD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating End-Stage Kidney Disease (end-stage renal disease or ESRD).
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Nephropathy Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Nephropathy Global Clinical Trials Review, H1, 2015" provides data on the Nephropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nephropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nephropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Polycystic Kidney Disease Global Clinical Trials Review, H1, 2015
Polycystic Kidney Disease Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, Polycystic Kidney Disease Global Clinical Trials Review, H1, 2015" provides data on the Polycystic Kidney Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polycystic Kidney Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Polycystic Kidney Disease. This report is built using data and information sourced from pro
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Proteinuria Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Proteinuria Global Clinical Trials Review, H1, 2015" provides data on the Proteinuria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Proteinuria. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Proteinuria. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Renal Failure Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Renal Failure Global Clinical Trials Review, H1, 2015" provides data on the Renal Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Renal Stones/Calculi Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Renal Stones/Calculi Global Clinical Trials Review, H1, 2015" provides data on the Renal Stones/Calculi clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Stones/Calculi. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Stones/Calculi. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Power Quarterly Deals Analysis: M&A and Investment Trends - Q4 2014
GlobalDatas Power Quarterly Deals Analysis: M&A and Investment Trends Q4 2014 report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity (PE), venture financing and partnership transactions recorded in the power industry in Q4 2014. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, categorized into deal types, segments and geographies. The report also provides information on the top PE, venture capital (VC) and advisory firms in the power industry. GlobalData derived the data presented in this report from proprietary in-house Power eTrack deals datab
Published Date: Feb 2015
Published By: GlobalData

Price: $1500
Power Monthly Deal Analysis - January 2015: M&A and Investment Trends
GlobalData's Power Monthly Deal Analysis January 2015: M&A and Investment Trends report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the power industry in January 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the power industry. Data presented in this report is derived from GlobalDatas proprietary in-house Power eTrack deals database and pri
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Saudi Arabia Power Market Outlook to 2030, Update 2015 - Market Trends, Regulations, and Competitive Landscape
This report elaborates Saudi Arabias power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Saudi Arabian power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Saudi Arabia on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential. Financial performance of the leading power companies is also analyzed in the report. Scope Snapshot of the countrys power sector across parameters macro economics, supply security, genera
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014
GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals Q4 2014 report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q4 2014. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry. Data presented in
Published Date: Feb 2015
Published By: GlobalData

Price: $1500
Mauritania Tevet Project Panorama - Oil and Gas Upstream Analysis Report
Mauritania Tevet Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geology, challenge
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Athletes Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015
GlobalDatas clinical trial report, Athletes Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015" provides data on the Athletes Foot (Tinea Pedis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Athletes Foot (Tinea Pedis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Athletes Foot (Tinea Pedis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-hou
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
Siemens Healthcare - Product Pipeline Analysis, 2015 Update
Siemens Healthcare (formerly Siemens Medical Solutions) is a global medical device company. It undertakes the design, development, manufacture and distribution of medical devices and technologies for diagnostic markets. It offers imaging equipment, healthcare information systems, management consulting, and support services. It has a comprehensive portfolio of medical solutions, ranging from medical imaging, in vitro diagnostics, and interventional systems to clinical IT. It conducts operations in North America, Africa, Europe, Asia and Australia. Siemens Healthcare is a business unit of Siemens AG and is headquartered in Erlangen, Germany.The company focuses on innovation to develop new products and expand its markets in BRIC countries (Brazil, Russia, India and China). With an intent to
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Instrumentation Laboratory Company - Product Pipeline Analysis, 2015 Update
Instrumentation Laboratory Company (IL) is a medical device company with focus on in vitro diagnostics (IVD) devices. The company carries out the development, manufacture and distribution of IVD instruments, related reagents and controls for use in hospitals and clinical laboratories. Its major products include critical care systems, hemostasis systems and information management systems. It also offers various quality control productsand services such as data management, clinical support and product support. The company has operations in the UK, France, Italy, Uruguay, Belgium, Germany, Mexico, Japan, Austria, the Netherlands, Hong Kong, and the US, among other countries.  IL is a subsidiary of Werfen Group and is headquartered in Bedford, Massachusetts, the US. This report is a
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Beckman Coulter, Inc. - Product Pipeline Analysis, 2015 Update
Beckman Coulter, Inc. (Beckman) is a medical device company. It undertakes the manufacture and marketing of biomedical laboratory instruments, software and supplies that simplify, automate and innovate complex biomedical tests. Its products are used in a wide range of applications such as medical research, clinical trials and drug discovery, and diagnostic laboratories in hospitals. The company has three divisions, namely, Research and Discovery, Diagnostics and Industrial. It operates across the US, Canada, Europe and Asia. Its products are sold in over 160 countries worldwide. The company has an installed base of over 275,000 clinical and research systems operating in laboratories around the world. Beckman is a subsidiary of Danaher Corporation, and is headquartered in California, the
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Oncgnostics GmbH - Product Pipeline Analysis, 2015 Update
Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company. It is involved in developing molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company’s technology GynTect is a new system based on   the detection of epigenetic biomarkers, especially the methylation of specific DNA regions. Its GynTect is a new triage assay which allows a fast and reliable detection of cervical precancerous lesions and cancer. The company also focuses on various other types of cancers such as ovarian cancer and head and neck tumors.  It has its operations all over the country. Oncgnostics is headquartered in Jena, Germany. This report is a source for data, analysis, and actionable intelligence on the company&rs
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Hemiplegia Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Hemiplegia Global Clinical Trials Review, H1, 2015" provides data on the Hemiplegia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemiplegia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemiplegia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope
Published Date: Feb 2015
Published By: GlobalData

Price: $2500
W. L. Gore and Associates, Inc. - Product Pipeline Analysis, 2015 Update
W. L. Gore & Associates, Inc. (Gore) carries out the manufacture and marketing of fluoro-polymer products for the medical, electronics, nuclear, fabrics and industrial markets. The company’s medical division provides surgeons and patients a variety of surgical products and medical OEM products. Its implants portfolio includes materials and components that solve complex medical problems in vascular, endovascular, interventional, general surgery and cardiothoracic, oral and orthopedic procedures. Gore caters to aerospace, automotive, chemical processing, computer, telecommunications, electronics, energy, environmental, industrial, manufacturing, military, pharmaceutical, biotechnology, and textile markets. The company has manufacturing facilities in the US, Scotland, Germany, Chi
Published Date: Feb 2015
Published By: GlobalData

Price: $750
EKF Diagnostics Holdings plc (EKF) - Product Pipeline Analysis, 2015 Update
EKF Diagnostics Holdings plc (EKF Diagnostics) is a medical device company. It designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company’s product portfolio comprises HbA1c analyzers, hemoglobin analyzers, glucose analyzers, lactate analyzers, rapid and sepsis testing kits, reagents, and biomarkers. These products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine.  It offers these products in more than 100 countries throughout the world through subsidiaries, and distributors under brands such as Quo-Lab, HemataStat, DiaSpect, STAT-Site, UltraCrit, Lactate Scout+, QuPID, True
Published Date: Feb 2015
Published By: GlobalData

Price: $750
FUJIFILM Medical Systems USA, Inc. - Product Pipeline Analysis, 2015 Update
FUJIFILM Medical Systems USA, Inc. (Fujifilm Medical) is a medical device company. It is one of the leading providers of medical imaging and information products and technologies for the diagnostic imaging markets. Its products acquire, process, manage, and store diagnostic images and related data. The company’s major products include radiology systems, cardiovascular systems, direct radiography (DR) systems, computed radiology (CR) systems (digital X-ray), endoscopes, digital mammography systems, ultrasound systems and dry imagers and film/screen. The company also provides integration and technical support services. Fujifilm Medical is a wholly owned subsidiary of FUJIFILM Holdings America Corporation and is headquartered in Stamford, Connecticut, the US. This report is a sourc
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Genentech, Inc. - Product Pipeline Analysis, 2015 Update
Genentech, Inc. (Genentech) is one of the world's leading biotech companies. The company undertakes research, development, manufacture, and marketing of biotherapeutics. Genentech focuses on developing drugs for unmet medical needs in the areas of cancer, immunological diseases and angiogenic disorders. Some of its major products include Rituxan, Avastin, Herceptin, Tarceva, Lucentis, Xolair, Pulmozyme and Activase. Its research activities focus on areas of cancer, metabolism, immunology, infectious disease and neuroscience. Its clinical development pipeline includes small molecules, monoclonal antibodies, and antibody drug conjugates. The company operates as a wholly owned subsidiary of Roche following its acquisition in 2009. The company is headquartered in South San Francisco, Califor
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Nigeria Oso Project Panorama - Oil and Gas Upstream Analysis Report
Nigeria Oso Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geology, challenges, re
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Nigeria Ovo Project Panorama - Oil and Gas Upstream Analysis Report
Nigeria Ovo Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential. Scope Overview of the asset based on an analysis of the economic indicators Key financial indicators including Net Present Value and Internal Rate of Return Review of factors affecting the economic outcome of the field including development overview, geology, challenges, re
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Salamander Energy plc, Company Intelligence Report
Salamander Energy (Salamander) is an upstream oil and gas company with a specific focus on exploration and production in Asia. The company was formed in 2005 and has its core assets in Thailand and Indonesia, with additional interests in Malaysia and Laos. In Thailand, Salamander has acreage positions in Greater Bualuang, which consists of the Bualuang oil field, reportedly the companys flagship producing asset. In Indonesia, the company has interests in licenses located in the Greater Kerendan area and North Kutei. Apart from these core assets, Salamander also has interests in the Kutai Production Sharing Contract (PSC) and the south Sokang PSC, in east Kalimantan and Natuna Sea respectively. In Thailand, the companys non-core assets comprise of its interests in blocks EU1, E5N and L1
Published Date: Feb 2015
Published By: GlobalData

Price: $1000
Refining Industry Outlook in Asia and Oceania to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries
Refining Industry Outlook in Asia and Oceania to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries" is a comprehensive report on crude oil refining industry in Asia and Oceania. The report provides refinery details such as refinery name, country, and refinery operator name, with in-depth coverage on crude distillation unit or, CDU capacity and other major unit capacities for all active and planned refineries in the region. The report also provides refinery capital expenditure outlook for Asia and Oceania till 2019. The report provides key country comparisons within a region based on contribution to regional refining capacity as well as refining capacity growth. Further, the report also offers recent developments as well as latest tende
Published Date: Feb 2015
Published By: GlobalData

Price: $5000
Refining Industry Outlook in Europe to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries
Refining Industry Outlook in Europe to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries" is a comprehensive report on crude oil refining industry in Europe. The report provides refinery details such as refinery name, country, and refinery operator name, with in-depth coverage on crude distillation unit or, CDU capacity and other major unit capacities for all active and planned refineries in the region. The report also provides refinery capital expenditure outlook for Europe till 2019. The report provides key country comparisons within a region based on contribution to regional refining capacity as well as refining capacity growth. Further, the report also offers recent developments as well as latest tenders and contracts for countries
Published Date: Feb 2015
Published By: GlobalData

Price: $5000
Refining Industry Outlook in North America to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries
Refining Industry Outlook in North America to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries" is a comprehensive report on crude oil refining industry in North America. The report provides refinery details such as refinery name, country, and refinery operator name, with in-depth coverage on crude distillation unit or, CDU capacity and other major unit capacities for all active and planned refineries in the region. The report also provides refinery capital expenditure outlook for North America till 2019. The report provides key country comparisons within a region based on contribution to regional refining capacity as well as refining capacity growth. Further, the report also offers recent developments as well as latest tenders and co
Published Date: Feb 2015
Published By: GlobalData

Price: $5000
EpiCast Report: Insomnia - Epidemiology Forecast to 2023
GlobalData epidemiologists forecast that the total prevalent cases of acute insomnia in the 7MM will increase from 121,799,911 total prevalent cases in 2013, to 130,482,156 total prevalent cases in 2023 at an Annual Growth Rate (AGR) of 0.71%. GlobalData epidemiologists forecast an increase in the total prevalent cases of chronic insomnia (not fulfilling DSM-IV criteria) in the 7MM from 62,982,390 total prevalent cases in 2013, to 67,471,957 total prevalent cases in 2023 at an AGR of 0.71%. The 7MM had an estimated 23,690,040 total prevalent cases of chronic primary insomnia in 2013 and the number of total prevalent cases is expected to increase to 25,378,728 by 2023, at an AGR of 0.71%. GlobalData epidemiologists forecast that the total prevalent cases of chronic secondary insomnia in
Published Date: Feb 2015
Published By: GlobalData

Price: $3995
Clean Coal Technologies, Update 2014 - Global Market Size, Trends, Regulations and Key Country Analysis to 2025
GlobalData, the industry analysis specialist, has released its latest research, “Clean Coal Technologies, Update 2014 Global Market Size, Trends, Regulations and Key Country Analysis to 2025”, which provides in-depth analysis of the clean coal technologies market at global and key country level. The term “clean coal” usually refers to the minimization of carbon emissions and other pollutants in coal-fired power generation. Supercritical (SC), Ultra Supercritical (USC), Circulating Fluidized Bed (CFB) technologies, Integrated Gasification Combined Cycle (IGCC) are termed as clean coal technologies. These can be used to improve the efficiency of existing coal-fired power plants and reduce the amount of CO2 emissions for the same amount of power generated. Scop
Published Date: Feb 2015
Published By: GlobalData

Price: $3995
Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015" provides data on the Spinocerebellar Ataxias clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spinocerebellar Ataxias. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spinocerebellar Ataxias. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by
Published Date: Jan 2015
Published By: GlobalData

Price: $2500
Tay-Sachs Disease Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Tay-Sachs Disease Global Clinical Trials Review, H1, 2015" provides data on the Tay-Sachs Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tay-Sachs Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tay-Sachs Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of ind
Published Date: Jan 2015
Published By: GlobalData

Price: $2500
W&T Offshore, Inc., Company Intelligence Report
W&T Offshore is Houston-based oil and natural gas company that is actively involved in the exploration, development and acquisition of oil and natural gas properties, located onshore and offshore in the US. W&T Offshore is primarily operating in the Deepwater Gulf Of Mexico (GOM), the GOM shelf, and the Permian Basin of West Texas. As of December 31, 2013, the companys 1P reserves totaled 119.6 million barrels of oil equivalent (mmboe) and its estimated 2P reserves totaled 169.6 mmboe. W&T Offshore reported overall production of 18 mmboe in 2013, representing an annual increase of around 5% over the 17.1 mmboe of production recorded in 2012. W&T Offshore possess 268,000 net acres in Deepwater GOM as of November 11, 2014. As of December 31, 2013, the company has 25.2
Published Date: Jan 2015
Published By: GlobalData

Price: $1000
Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015" provides data on the Non Alcoholic Fatty Liver Disease (NAFLD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non Alcoholic Fatty Liver Disease (NAFLD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non Alcoholic Fatty Liver Disease (NAFLD). This report is built using data and information sourced from proprie
Published Date: Jan 2015
Published By: GlobalData

Price: $2500
Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2015" provides data on the Nonerosive Reflux Disease (NERD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonerosive Reflux Disease (NERD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonerosive Reflux Disease (NERD). This report is built using data and information sourced from proprietary databases, primary and secondar
Published Date: Jan 2015
Published By: GlobalData

Price: $2500
Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2015" provides data on the Post Operative Nausea And Vomiting clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post Operative Nausea And Vomiting. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Post Operative Nausea And Vomiting. This report is built using data and information sourced from proprietary databases, primary and
Published Date: Jan 2015
Published By: GlobalData

Price: $2500
Steatohepatitis Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Steatohepatitis Global Clinical Trials Review, H1, 2015" provides data on the Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Steatohepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry ex
Published Date: Jan 2015
Published By: GlobalData

Price: $2500
Alpha - Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015
GlobalDatas clinical trial report, AlphaAntitrypsin Deficiency Global Clinical Trials Review, H1, 2015" provides data on the AlphaAntitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on AlphaAntitrypsin Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating AlphaAntitrypsin Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-hou
Published Date: Jan 2015
Published By: GlobalData

Price: $2500
Power Monthly Deal Analysis - December 2014: M&A and Investment Trends
GlobalData's Power Monthly Deal Analysis December 2014: M&A and Investment Trends report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the power industry in December 2014. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the power industry. Data presented in this report is derived from GlobalDatas proprietary in-house Power eTrack deals database and p
Published Date: Jan 2015
Published By: GlobalData

Price: $1000